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protein Hspb8. While the homozygous knock-in mice 
developed motor deficits associated with degeneration of 
peripheral nerves and severe muscle atrophy corroborating 
patient data, homozygous knock-out mice had locomotor 
performances equivalent to those of wild-type animals. The 
distal skeletal muscles of the post-symptomatic homozygous 
knock-in displayed Z-disk disorganisation, granulofilamen-
tous material accumulation along with Hspb8, αB-crystallin 
(HSPB5/CRYAB), and desmin aggregates. The presence of 
the aggregates correlated with reduced markers of effective 
autophagy. The sciatic nerve of the homozygous knock-in 
mice was characterized by low autophagy potential in pre-
symptomatic and Hspb8 aggregates in post-symptomatic 
animals. On the other hand, the sciatic nerve of the homozy-
gous knock-out mice presented a normal morphology and 
their distal muscle displayed accumulation of abnormal 
mitochondria but intact myofiber and Z-line organisation. 
Our data, therefore, suggest that toxic gain-of-function 
Abstract Mutations in the small heat shock protein B8 
gene (HSPB8/HSP22) have been associated with distal 
hereditary motor neuropathy, Charcot–Marie–Tooth dis-
ease, and recently distal myopathy. It is so far not clear how 
mutant HSPB8 induces the neuronal and muscular pheno-
types and if a common pathogenesis lies behind these dis-
eases. Growing evidence points towards a role of HSPB8 in 
chaperone-associated autophagy, which has been shown to 
be a determinant for the clearance of poly-glutamine aggre-
gates in neurodegenerative diseases but also for the mainte-
nance of skeletal muscle myofibrils. To test this hypothesis 
and better dissect the pathomechanism of mutant HSPB8, 
we generated a new transgenic mouse model leading to the 
expression of the mutant protein (knock-in lines) or the loss-
of-function (functional knock-out lines) of the endogenous 
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of mutant Hspb8 aggregates is a major contributor to the 
peripheral neuropathy and the myopathy. In addition, mutant 
Hspb8 induces impairments in autophagy that may aggravate 
the phenotype.
Keywords Peripheral neuropathy · Myofibrillar 
myopathy · HSPB8 · Autophagy
Introduction
Distal hereditary motor neuropathies (dHMN) are a group of 
clinically and genetically heterogeneous disorders character-
ized by the degeneration of motor axons in the peripheral 
nervous system [35]. In dHMNtype II, lower motor neurons 
are typically involved, whereas sensory functions are mainly 
spared and symptoms can rapidly evolve into weakness of 
lower distal muscles and severe neurogenic muscular atro-
phy [77]. We and others identified two dominant missense 
mutations targeting the same lysine 141 residue, the K141N 
(Lys141Asn) and K141E (Lys141Glu) in the highly con-
served α-crystallin domain of the small heat shock protein 
B8 gene (HSPB8/HSP22) causative of dHMNtype II [24, 
43, 76, 77]. Identical and additional mutations at Lys141 
were associated with Charcot–Marie–Tooth disease type 2L 
(CMT2L), which differs from dHMN by its sensory involve-
ment [55, 74], and recently with distal myopathy [25, 34]. 
In the latter case, patients with K141E or frameshift muta-
tion in HSPB8 presented a progressive myopathy associated 
with myofibrillar network disruption and rimmed vacuolar 
pathology reminiscent of myofibrillar myopathy (MFM) 
hallmarks [17, 47]. Despite the growing interest in the bio-
logical role of HSPB8 and the consequence of its mutation, 
the pathogenesis of the neuromuscular phenotype in patients 
with mutant HSPB8 remains to be solved.
The HSPB8 is one of the ten members of the small 
heat shock protein family (sHSP), a group of molecular 
chaperones known to be up-regulated under heat stress or 
toxic stress. All the members of the sHSP family share a 
highly conserved α-crystallin domain and a remarkable 
ability to form large dynamic oligomers whose composi-
tion and stoichiometry regulate their function [36]. The 
sHSPs participate in the proteome integrity by binding 
to the hydrophobic regions of misfolded and non-native 
proteins in stressful conditions. Besides their canonical 
function in proteostasis, sHSPs have been involved in 
an increasing number of cellular functions in stress and 
physiological conditions such as cellular differentiation 
and proliferation, translation, oxidative stress regulation, 
cytoskeleton stabilisation, apoptosis, and autophagy [1, 3, 
19, 33, 39, 59, 86]. Interestingly, mutations in HSPB1 and 
αB-crystallin, two other members of the same sHSP fam-
ily, have also been associated with inherited peripheral 
neuropathies [11, 24, 27, 48, 63, 68], and distal myopathy, 
respectively [28, 53, 82]. The reason why mutations in 
those ubiquitous chaperones affect specifically periph-
eral nerves and muscle is unclear. A number of papers 
published by Carra et al. demonstrated how HSPB8 par-
ticipates in aggregates clearance through its interaction 
with the Beclin2 Associated Anathogen 3 (BAG3) com-
plex [13–15]. Dimers of HSPB8 bind to the co-chaperone 
BAG3 which allow the ubiquitination of the to-be-cleared 
substrate via its interaction with the heat shock protein 70 
(HSP70) and CHIP (carboxyl terminus of HSC70-inter-
acting protein) complex. Once ubiquitinated, the substrate 
is identified by sequestosome-1 (SQSTM1), also known 
as the ubiquitin-binding protein p62, and engulfed by 
the autophagosome for degradation in a process called 
macroautophagy. The involvement of the HSPB8/BAG3 
complex in the clearance of aggregates associated with 
neurodegenerative diseases such as Huntington’s disease, 
frontotemporal dementia, amyotrophic lateral sclerosis, 
and spinobulbar muscular atrophy supports a key role of 
this chaperone-mediated autophagy in the maintenance of 
neurons in general and motor neurons in particular [14, 
16, 22, 65]. Interestingly, the K141N and K141E mis-
sense mutations in HSPB8 associated with dHMN and 
myopathy reduce the ability of HSPB8 to bind to BAG3, 
and impair the degradation of aggregates via autophagy 
in  vitro and in  vivo [12, 50]. The interaction of the 
HSPB8/BAG3 complex with HSC70 (the cognate form 
of HSP70) and p62 (p62/SQTM1) is also essential in skel-
etal muscle maintenance where it promotes the degrada-
tion of the actin-crosslinking protein Filamin C damaged 
by muscle contraction [2, 80]. Accordingly, mutation or 
deficiency in p62, BAG3, and HSPB8 has been shown to 
induce distal myopathy associated with rimmed vacuole 
and myofibrillar disorganisation on muscle biopsy [10, 
25, 34, 40, 49, 71]. New roles are also emerging for the 
HSPB8/BAG3 complex in actin dynamics, spindle orien-
tation, mitosis, and stress granule regulation [30, 31, 81] 
and for HSPB8 in mitochondria oxidative phosphoryla-
tion and membrane potential maintenance [42, 52, 54, 
62]. In addition, mutations in HSPB8 can, in vitro, induce 
HSPB8 aggregation [42], increase its binding to the RNA 
helicase Ddx20 [73], and several heat shock proteins [29, 
42], as well as impair the ability of primary neurons to 
form neurites in vitro [41]. It is, therefore, difficult to pin-
point to a main function altered by mutant HSPB8 which 
could be responsible for the neuropathic and myopathic 
phenotypes. In this study, we developed a new transgenic 
mouse model using the endogenous Hspb8 promoter that 
allowed the generation of mutant Hspb8 knock-in (KI) 
lines as well as Hspb8 functional knock-out (KO) lines 
to achieve better understanding of HSPB8-related neuro-
muscular pathogenesis.
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Materials and methods
Ethics statement
All mouse experiments were carried out with approval of 
the Ethical Committee for Laboratory Animals (University 
of Antwerp). Mice were housed under the care of the Ani-
mal Facility Interfaculty Unit, which is accredited by the 
Association for Assessment and Accreditation of Laboratory 
Animals. All experiments were performed on adult female 
 Hspb8K141N/K141N (knock-in, KI);  Hspb8−/− (knock-out, KO); 
and  Hspb8+/+ (wild type, WT) mice; except when otherwise 
stated.
Generation of the HspB8 targeting vector
A single targeting vector was generated to produce 
 Hspb8K141N KI and Hspb8 KO transgenic mouse lines. 
Briefly, the BAC clone bMQ-191J17 (Geneservice, Cam-
bridge, UK) containing the full length mouse Hspb8 
genomic DNA was used as starting material. The Neomy-
cin (Neo) selection gene, floxed by Flp recombinase target 
(FRT) sites and followed by a loxP site, was retrieved from a 
pPGK-loxPFRT-Neo-FRT plasmid (gift from D. J. van Hen-
gel, VIB Department for Molecular Biomedical Research, 
Ghent). Through PCR, a loxP site upstream of exon 2 was 
added, as well as specific restriction sites to allow fur-
ther cloning, Southern blot analysis, and genotyping. The 
restriction enzymes used were AatII, BamHI, EcoRV, Hin‑
dIII, MluI, NotI, SacII, SexAI, and XhoI (New England 
Biolabs, Ipswich, MA, USA). In a first step, all fragments 
were cloned individually in a pCR2.1_TOPO vector (Life 
Sciences, Little Chalfont, UK). Next, in vitro mutagenesis 
was performed to insert the K141N (c.423 G > C) muta-
tion in the exon 2 of the Hspb8 gene. The final targeting 
vector contained (1) the K141N point mutation in exon 2 
of the Hspb8 gene; (2) the Neo gene cassette, downstream 
of hspb8 exon 2; (3) two loxP sites to allow the excision of 
exon 2 and the Neo cassette to generate a functional Hspb8 
KO mouse line.
Chimeric mouse generation and breeding
The linearized targeting vector was electroporated in G4 
embryonic stem cells (G4 ES, Mount Sinai, Toronto, CA) 
[32]. Clones were selected for resistance to neomycin and 
screened for correct targeting by PCR, Multiplex Ampli-
con Quantification (Multiplicom, Antwerp, Belgium) and 
Southern blot. Correctly targeted cells (from 29/A10 ES 
cell clone) were aggregated with outbred Swiss morula, 
which were then implanted into pseudopregnant Swiss 
mice. The ES cell manipulations and transgenic mouse 
generation were performed by T.H., S.G., and J.J.H. This 
led to the generation of a transgenic line having the K141N 
mutation integrated in the exon 2 of the endogenous mouse 
Hspb8 gene. Transgenic mice from the F2-generation were 
backcrossed on a C57BL/6J genetic background. Homozy-
gous  Hspb8K141N/K141N, heterozygous  Hspb8K141N/+ trans-
genic mice, and wild-type littermates were obtained by 
crossing heterozygous  Hspb8K141N/+ lines. Heterozygous 
 Hspb8K141N/+ lines were also crossed with Sox2-Cre lines to 
generate functional Hspb8 KO mice after exon 2 excision by 
Cre-lox recombination and obtain heterozygous  Hspb8−/+, 
homozygous  Hspb8−/−, and wild-type littermates.
PCR analyses and sequencing
ES screening and genotyping of transgenic animals was per-
formed by PCR on a Veriti 96 well Thermal Cycler (Applied 
Biosystems, Thermo Fisher Scientific Inc., Waltham, MA, 
USA) using 4 primer sets. The primers for the distinction of 
the WT and KI allele were as follows: LoxP_Fw, ATC TTG 
AAG CAT TGA AGC AAGG (forward primer) and LoxP_Rv, 
TAT TGA AAT ACG GAC TGA GTGGG (reverse primer). The 
PCR reaction resulted in a 188 bp fragment corresponding 
to the WT allele and/or a 235 bp fragment corresponding to 
the KI allele. The KO allele was detected by an amplicon of 
390 bp using the following primers: KO_Fw CAG CAT CTT 
GAA GCA TTG AAGC and KO_Rv AGC ACA AGG GTC CAT 
ATA CTC CAG . The primers for the detection of the CRE 
recombinase transgene were CRE5 ATG TCC AAT TTA 
CTG ACC G and CRE3 CGC CGC ATA ACC AGT GAA . The 
genotype was validated by sequencing exon 2 of the Hspb8 
mouse gene after amplification by PCR using the following 
primers: Hspb8_exon2_Fw GGA AGT TAG GGA GCA GGT 
GTCC and Hspb8_exon2_Rv GGA AGT TAG GGA GCA 
GGT GTCC. The PCR contained standard 10× PCR buffer, 
50 mM  MgCl2 (for the KO and Cre PCR) or 1 M betain (for 
Exon2 and LoxP PCR), 10 mM dNTPs, 0.10 µM of each 
primer, and 1 unit of Platinum Taq Polymerase (Clontech 
Laboratories, Mountain View, CA, USA) for the KO and Cre 
PCR. We used Titanium Taq polymerase (Clontech Labo-
ratories, Mountain View, CA, USA) to perform the Exon 
2 and LoxP PCR on 100 ng genomic DNA isolated from 
mouse ear or tail biopsies. The PCR conditions for ampli-
fication of Exon 2, LoxP, and KO were as follows: initial 
denaturation for 5 min at 95 °C followed by 35 cycles of 45 s 
denaturation at 95 °C, 45 s primer annealing at 68 °C (for 
the Exon2 PCR), 66 °C (for the LoxP PCR), or 60 °C (for 
the KO PCR) and a final extension of 5 min at 68 °C (for the 
Exon2 and Lox PCR) or 72 °C (for the KO PCR). The Cre 
PCR condition was as follows: initial denaturation for 2 min 
at 95 °C followed by 40 cycles of 30 s at 95 °C, 1 min at 
58 °C, and 1 min at 72 °C, and a final extension of 10 min at 
72 °C. PCR products were detected on 2 or 3% (for the LoxP 
PCR product) agarose gels. The genotype was validated by 
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sequencing the exon 2 of the mouse Hspb8 gene. Sequencing 
was performed on purified DNA using the  BigDye® Ter-
minator v3.1 Cycle Sequencing Kit (Applied Biosystems, 
Thermo Fisher Scientific Inc., Waltham, MA, USA) and 
separated on an ABI3730xl DNA Analyser (Applied Biosys-
tems, Thermo Fisher Scientific Inc., Waltham, MA, USA). 
Resulting DNA sequences were aligned and analysed with 
the CLC Main workbench software.
Behavioural phenotype of the mice
All behavioural experiments were carried out according to 
the recommendation of the Ethical Committee for Labora-
tory Animals (University of Antwerp). The motor and sen-
sory functions were assessed at 3, 6, 9, 12, and 18 months of 
age in adult female mice. The behavioural assessment was 
performed by an experimenter blind to the mice genotype.
Tail suspension test
Each mouse was lifted up by the tail at a height of approx-
imately 20 cm and the hind limb spreading reflex versus 
clasping behaviour was assessed.
Accelerating Rotarod
The locomotor performance was assessed with a five station 
Rotarod Treadmill for mouse (ENV-575 M, Med associates 
Inc., St Albans, VT, USA) according to the manufacturer’s 
instructions. Briefly, the mice were put in separated sections 
on an accelerating rotating rod (4–40 rpm over a 300-spe-
riod) and the latency to fall was recorded. The time spent 
clinging on the rotating rod without walking was subtracted 
from the final score. Each mouse was trained for 5 consecu-
tive days before each test.
Grip strength test
Four-limb grip strength was measured using the Bioseb grip 
strength tester BIO-G3S (Bioseb, Vitrolles, France). Mice 
were placed on a grid accessory and pulled firmly back-
wards by the tail, provoking a grip response. The maximum 
force exerted on the grid was recorded on the apparatus. 
The final score was determined by averaging the strength 
of three trials.
Footprint analysis
The analysis of the mice hind paw footprints was performed 
as previously described [85]. Briefly, the hind feet of the 
mice were coated with non-toxic black ink, so that the mice 
left a trail of footprints as they walked along a 50-cm-long, 
10-cm-wide runway. The toe spreading (distance between 
the first and last toe) and the plantar length (distance 
between the tip toe and the heel) of three consecutive steps 
were measured and averaged.
Hot plate test
The sensitivity to heat was measured using the IITC Life 
Science Hot plate analgesia meter (IITC Inc. Woodlands 
Hills, CA, USA) according to the manufacturer instruc-
tions. Briefly, each mouse was dropped in a bottom-less 
glass container placed on a platform heated at 52 °C. The 
temperature was chosen according to the mouse strain to 
produce a slight discomfort without inducing pain or injury. 
The latency before showing a sign of discomfort in the hind 
paws (licking, fast removal or jump) was recorded. Mice that 
did not show any sign of discomfort after 20 s were removed 
to prevent injury. The final score was determined by averag-
ing the reaction times of three trials.
Nerve conduction studies
Nerve conduction studies were performed using the Neuro-
EMG-Micro system (Neurosoft, Ivanovo, Russia). Subdermal 
0.4-mm electrodes were used for stimulation and recording on 
anesthetized mice (5% isoflurane). Compound muscle action 
potential amplitudes (CMAPs) were measured by placing the 
stimulating electrodes at the sciatic notch and the recording 
electrodes above the gastrocnemius muscle. The CMAPs were 
measured at supramaximal stimulation. Three consecutive 
recordings were performed. The highest recorded amplitude 
and the associated latency were used as final scores.
Tissue harvesting and processing
After inhalation of a lethal dose of  CO2, mice were dis-
sected and the sciatic nerve, spinal cord, and gastrocnemius 
muscles were harvested, snap frozen in liquid nitrogen, and 
stored at −80 °C for subsequent protein or mRNA analysis. 
For microscopy analysis, the tibial nerve (distal to the sciatic 
nerve trifurcation) and gastrocnemius were dissected and 
fixed in a 3.9% glutaraldehyde for 48 h at room temperature. 
For enzymatic staining, freshly dissected gastrocnemius was 
snap frozen in cold methyl butane, sliced in 9 µm cross-
sections, and stored at −80 °C until further processing. For 
staining on fixed sections, mice received a lethal dose of 
xylazine and ketamine mixture before being transcardially 
perfused with 4% paraformaldehyde (PFA). The spinal cord, 
sciatic nerve, and gastrocnemius muscle were harvested, 
post-fixed in 4% PFA overnight, and stored in 30% sucrose 
phosphate-buffered saline (PBS) solution.
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Histology
Morphometric study on epoxy semi‑thin sections and EM 
analysis
Nerve and muscle samples were stained with unbuffered 
aqueous 1% osmium tetroxide, dehydrated, and embedded 
in araldite epoxy resin. Semi-thin sections were cut on an 
ultra-microtome, stained with 1% toluidine blue, and exam-
ined by light microscopy. Images of toluidine blue sections 
were captured on an Axioskop light microscope (Zeiss, 
Oberkochen, Germany) equipped with a CCD UC30 camera 
(Olympus Inc., Tokyo, Japan). Morphometrical evaluation 
of the axon number in the tibial nerve was performed in sets 
of images covering the total nerve cross-sectional area using 
the software ImageJ [70]. The large and medium myelinated 
axons were manually counted and reported to the nerve area. 
In addition, samples were analysed using a semi-automatic 
method to obtain the myelinated fiber size distribution. To 
this end, images with overlapping regions of the entire nerve 
were acquired at 40× magnification (plan achromat objec-
tive, pixel size = 0.137 µm) and stitched together using the 
grid/collection stitching plugin [60] in Fiji software [69]. 
All stitched images were batch-processed with an ImageJ 
macro to measure the diameter of all individual axons with 
an automatic segmentation procedure using the Fiji plugin 
find connected regions after contrast normalization and 
unsharp mask, and followed by particle size filtering with 
the particles analysis tool. Transmission electron micros-
copy (TEM) of the glutaraldehyde-fixed, resin embedded 
tissue was performed as previously described [9]. All semi-
thin and EM analyses were done with biological triplicates 
(n = 3).
Staining and immunohistochemistry (IHC)
The fixed spinal cord lumbar enlargement (containing the 
neurons innervating the lower limbs) was sliced in 14 µm 
cross sections and stained with cresyl violet to allow neu-
ron quantification. The number of large neurons in the 
ventral horn of the spinal cord was manually counted using 
the software image J [70]. Gastrocnemius sections were 
processed for hematoxylin/eosin and ATPase stainings or 
immunostaining using the following antibodies: Hspb8 
(ab79784, Abcam, Cambridge, UK), αB-crystallin (ADI-
SPA-222-D, Enzo life science, Farmingdale, NY, USA), 
and desmin (M076029, Dako, Agilent, Santa Clara, CA, 
USA). The fixed sciatic nerve was sliced in 7 µm lon-
gitudinal sections and immunostained for Hspb8 and 
BAG3 (A302-806A-M, Bethyl Laboratories, Montgom-
ery, TX, USA). Immunohistochemistry was performed as 
previously described [8]. Briefly, after blocking endog-
enous peroxidases and unspecific epitopes, sections were 
incubated overnight at 4 °C with the primary antibody, 
1 h at room temperature with a horse-radish peroxidase 
(HRP)-conjugated secondary antibody (Jackson Immuno 
Research Laboratories Inc., West Grove, PA, USA) and 
developed using 3,3′-diaminobenzidine (DAB). Sections 
were counterstained with hematoxylin. Images were taken 
on an Axioskop light microscope (Zeiss, Oberkochen, 
Germany) equipped with a CCD UC30 camera (Olympus 
Inc., Tokyo, Japan). All stainings were done on biological 
triplicates (n = 3).
Western blot analysis
Samples were homogenized in RIPA buffer (50 mM Tris, 
150  mM NaCl, 1% NP40, 0.5% Sodium deoxycholate, 
and 0.1% Sodium Dodecyl Sulphate) complemented with 
protease inhibitors (Complete, Roche Diagnostics, Basel, 
Switzerland) and phosphatase inhibitors (PhosStop, Roche, 
Basel, Switzerland). Equal concentrations of proteins, as 
determined by the BCA protein assay (Thermo Fisher Scien-
tific, Waltham, MA, USA), were mixed with NuPAGE LDS 
sample buffer, heated to 95 °C for 10 min, and then sepa-
rated by NuPAGE Bis–Tris gel (4–12% polyacrylamide), 
electro-transferred (XCell SureLock, Invitrogen, Thermo 
Fisher Scientific, Waltham, MA, USA) onto Nitrocellulose 
membrane and immunoblotted. Briefly, membranes were 
blocked in 5% non-fat dry milk in PBS-Tween (0.1%) for 
1 h at room temperature and incubated overnight at 4 °C 
with a primary antibody. The membranes were incubated 
with HRP-linked secondary antibody treated with Enhanced 
Chemiluminescence ECL Plus kit reagents (Thermo Fisher 
Scientific, Waltham, MA, USA) and imaged with Image-
Quant imager (GE Healthcare, Wauwatosa, WI, USA). The 
following antibodies were used: Hsp22 (3059, Cell Signal-
ing, Danvers, MA, USA), N-terminal Hsp22 (SAB2101100, 
Sigma-Aldrich, St Louis, MO, USA), BAG3 (A302-
806A-M, Bethyl Laboratories, Montgomery, TX, USA), 
LC3B (L7543, Sigma-Aldrich, St Louis, MO, USA), p62 
(sc-25575, Santa Cruz Biotechnology Inc., Dallas, TX, 
USA), GAPDH (GTX627408, Gene Tex Inc., Irvine, CA, 
USA), and the following HRP-conjugated secondary anti-
bodies: anti-mouse IgG1 (1070-05, Southern Biotec, Bir-
mingham, AL, USA), anti-mouse IgG2b (1090-05, Southern 
Biotec, Birmingham, AL, USA), and anti-rabbit (W401B, 
Promega, Madison, WI, USA). Western blots were quanti-
fied using ImageJ [70] software as previously described [39]. 
Briefly, band intensity was determined by the ‘mean pixel 
gray’ values after Gaussian blur and background subtraction. 
The ‘mean pixel gray’ value of each protein of interest was 
then normalized to the ‘mean pixel gray’ value of the load-
ing control and presented as relative quantities. All western 
blot analyses were run with biological triplicates (n = 3).
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Quantitative RT‑PCR
The frozen tissue was homogenized in Trizol and total RNA 
was extracted using the RNeasy lipid tissue kit (Qiagen, 
Venlo, The Netherlands) according to the manufacturer’s 
protocol. Possible residual DNA contamination was elimi-
nated by DNase treatment (Ambion, Thermo Fisher Scien-
tific Inc., Waltham, MA, USA). RNA was then converted 
into cDNA using the  SuperScript® III reverse transcriptase 
(life technologies, Carlsbad, CA, USA). Real-time quantita-
tive polymerase chain (RT-qPCR) reactions were done with 
10 ng cDNA diluted in SYBR Green mix (Life Technolo-
gies, Carlsbad, CA, USA) and run on a ViiA 7 Real-Time 
PCR System (Applied Biosystems, Thermo Fisher Scien-
tific Inc., Waltham, MA, USA) with gene-specific primers 
(mHspb8 5′-AGA CCC CTT TCG GGA CTC A-3′/5′-GGC TGT 
CAA GTC GTC TGG AA-3′). Primers were designed making 
use of Primerbank (http://www.pga.mgh.harvard.edu/prim-
erbank). One sample from each target was used as no-RT 
control to attest the absence of genomic DNA contamina-
tion. Relative gene expression was calculated using the 
ΔΔCT method [37] and normalized with geometric mean of 
at least three housekeeping genes. All quantitative RT-PCR 
analyses were run with biological triplicate.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 
version 6 (GraphPad, La Jolla, CA, USA). Differences 
between genotypes over different ages were tested using 
two-way repeated-measures ANOVA and Tukey’s post hoc 
analysis. Comparisons of two data sets were analysed by 
Student’s t test. Values are expressed as mean ± SD. Sta-
tistical significance was set at p < 0.05. All analyses were 
performed blind to the genotype of the mice.
Results
Generation of the Hspb8 KI and KO lines
The transgenic Hspb8 KI and KO mouse lines were gener-
ated using a single targeting vector encompassing K141N 
(c.423G > C) point mutation, responsible for dHMN [43], 
integrated in exon 2 of the endogenous mouse Hspb8 gene. 
We developed a gene targeting construct containing the 
mutated exon 2, a neomycin resistance (Neo) gene cassette 
downstream of exon 2 flanked by two FRT sites and two 
loxP sites (one situated upstream of exon 2 and the other 
downstream of Neo) (Fig. 1a). Male chimeras were used for 
germline transmission and F1-generation mice were back-
crossed to the C57BL/6J line to generate a stable colony 
carrying the  Hspb8K141N allele.  Hspb8K141N/+ mice were 
bred to generate  Hspb8K141N/K141N,  Hspb8K141N/+, and WT 
littermates  (Hspb8+/+). The functional KO mouse lines were 
activated by excision of exon 2 following Cre-lox recombi-
nation by crossing  Hspb8K141N mice with Sox2-Cre mice 
[51] (Fig. 1a). The mice genotype was identified by PCR 
using specific primers to detect Cre recombinase and to 
differentiate the WT allele (188 bp) from the KI (235 bp) 
allele (Fig. 1b), and to differentiate the WT or KI alleles 
(1335/1377 bp) from the KO allele (390 bp) (Fig. 1c). The 
presence of the K141N point mutation was further validated 
by Sanger sequencing (Fig. 1d). The homozygous KI mice 
had normal Hspb8 mRNA and protein levels in the spinal 
cord, where the protein is highly expressed (Fig. 1f–h), sug-
gesting that the point mutation is not affecting the transcrip-
tion or the protein stability in this tissue. In the functional 
KO mice, the excision of Hspb8 exon 2 did not significantly 
affect its mRNA expression (Fig. 1i). However, the protein 
could not be detected by western blot using an antibody tar-
geting an epitope coded by the exon 1 of the Hspb8 mouse 
gene (Fig. 1e). The generated transgenic mouse lines had a 
normal lifespan and weight. Their feeding, grooming, and 
mating behaviours were comparable to those of C57bl/6 
wild-type mice.
Hspb8K141N/K141N mice develop a progressive defect 
in motor functions
The  Hspb8K141N/K141N,  Hspb8K141N/+,  Hspb8−/−, and 
 Hspb8−/+ mice and their WT littermates were screened 
for motor or sensory deficits at 3, 6, 9, and 12 months of 
age. The KI lines  (Hspb8K141N/K141N,  Hspb8K141N/+) were 
also tested at 18 month. None of the mice showed clasping 
behaviour and no difference in footprint could be detected 
between the transgenic heterozygous and homozygous KI 
and KO mice and their respective WT littermates. From the 
age of 9 months, the homozygous mutant  Hspb8K141N/K141N 
mice showed a progressive and significant decline in the 
locomotor performance assessed by the Rotarod (Fig. 2a). A 
decline was also observed at the grip strength test where the 
 Hspb8K141N/K141N mice achieved a significantly lower per-
formance than their WT littermates at 18 month (Fig. 2c). 
However, the  Hspb8K141N/K141N mice score at the hot plate 
test was normal (Fig. 2e), suggesting that the sensory func-
tions were preserved. The motor deficit was further sup-
ported by a drastic and significant reduction of the amplitude 
of the compound motor action potentials (CMAPs) in the 
 Hspb8K141N/K141N mice from the age of 6 months onwards 
(Fig. 2g), while the nerve conduction velocities were nor-
mal, hinting for axonal loss rather than demyelination of the 
nerve. On the other hand, the heterozygous  Hspb8K141N/+ 
mice performances did not differ from the WT (Supplemen-
tary Fig. S1). These mice were, therefore, not included in 
further analyses. These data demonstrate that homozygous 
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Fig. 1  Generation and validation of the  Hspb8K141N KI and Hspb8 
KO lines. a Schematic representation of the mouse Hspb8 allele 
showing the Neomycin gene (Neo) flanked by two FRT sites upstream 
of exon 2. The exon 2 and the Neo gene are floxed by two loxP 
sites. Expression of the FLP recombinase allows excision of the 
Neo gene cassette, while expression of Cre recombinase allows Cre-
loxP recombination and excision of the exon 2 of the Hspb8 gene as 
well as the Neo cassette. b Photograph showing the products of the 
Exon 2_loxP genotyping by PCR. The 188 bp and 235 bp amplicons 
resulted from the amplification of the wild-type (WT) and mutant 
Hspb8 alleles, respectively. Lanes 1, 3, 5, and 6 represent genotypes 
of WT littermates, lane 2 of a homozygous KI animal, and lane 4 of 
a heterozygous KI animal. c Photograph showing the products of the 
KO genotyping by PCR. The 1335 and 390  bp amplicons resulted 
from the amplification of the wild-type Hspb8 allele and the allele 
lacking exon 2, respectively. The lanes 1–4 represent genotypes of 
WT animals; lanes 5–8 of homozygous KO animals. d Sequencing 
of the exon 2 of the mouse Hspb8 gene showing the presence of the 
point mutation in a single allele of an heterozygous and homozy-
gous animal. e Representative western blot analysis of mouse Hspb8 
protein level in the sciatic nerve of 2-month-old KO  Hspb8−/− mice 
(lanes 2, 4, and 6) and WT littermates (lanes 1, 3 and 5) showing that 
only the protein lysate from WT produces a band. GAPDH is used as 
a loading control. f Relative quantities (ΔΔCT) of Hspb8 mRNA in 
the spinal cord of 2-month-old  Hspb8K141N/K141N and  Hspb8+/+ mice. 
Values are expressed as mean ± SD, N = 3. g Representative western 
blot analysis of Hspb8 in the spinal cord of 2-month-old  Hspb8K141N/
K141N and  Hspb8+/+ mice and quantification of Hspb8 bands normal-
ized on GAPDH (h). Values are expressed as mean ± SD, N = 3. i 
Relative quantities (ΔΔCT) of Hspb8 mRNA in the spinal cord of 
2-month-old  Hspb8−/− and  Hspb8+/+ mice. Values are expressed as 
mean ± SD, N = 3
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expression of  Hspb8K141N mutation induces motor behav-
ioural and electrophysiological impairments without sen-
sory abnormalities similar to the dHMN type II phenotype 
[75]. Interestingly, neither the homozygous  Hspb8−/− mice 
(Fig. 2) nor the heterozygous  Hspb8−/+ (Supplementary 
Fig. S1) developed motor or sensory deficits or CMAPs 
abnormalities suggesting that part of the motor phenotype 
observed in the  Hspb8K141N/K141N mice is the consequence 
of a toxic gain-of-function of the mutant protein.
Hspb8K141N/K141N mice show severe axonal degeneration
To determine if the reduced CMAPs amplitude was associ-
ated with axonal degeneration, we quantified the number of 
myelinated axons on Toluidine blue-stained semi-thin cross 
sections of the distal sciatic nerve (tibial nerve) of 18-month-
old  Hspb8K141N/K141N mice (Fig. 3b) and their WT littermates 
(Fig. 3a). The densities of large and medium myelinated 
axons were significantly lower in the  Hspb8K141N/K141N mice 
Fig. 2  Assessment of motor 
and sensory functions in the 
 Hspb8K141N KI and Hspb8 KO 
lines. a, b Rotarod performance 
showing the average time, 
in seconds (s), spent on the 
accelerating rotating rod at 3, 
6, 9, 12, and 18 months of age 
in  Hspb8K141N/K141N mice and 
their WT littermates (a) and at 
3, 6, 9, and 12 months of age 
in  Hspb8−/− mice and their WT 
littermates (b). c, d Average 
score on the grip strength over 
time in  Hspb8K141N/K141N mice 
and their WT littermates (c) 
and in  Hspb8−/− mice and their 
WT littermates (d). e, f Hind 
paws sensitivity to heat shown 
by the average reaction time, 
in milliseconds (ms), before 
showing a sign of discomfort 
in  Hspb8K141N/K141N mice 
and their WT littermates (e) 
and in  Hspb8−/− mice and 
their WT littermates (f). g, h 
Average CMAPs amplitude 
in  Hspb8K141N/K141N mice and 
their WT littermates (g) and 
in  Hspb8−/− mice and their 
WT littermates (h). Values are 
expressed as mean ± SD, N = 9. 
*p<0.05, and **p<0.01
a b
c
g
d
Hspb8+/+
Hspb8K141N/K141N
Hspb8+/+
Hspb8-/-
fe
h
*
* *
3 6 9 12 18
0
50
100
150
200
250
300
350
age (months)
tim
e 
sp
en
t o
n 
th
e 
R
ot
ar
od
 (s
)
*
**
** **
3 6 9 12 18
0
20
40
60
80
100
120
age (months)
C
M
A
Ps
 a
m
pl
itu
de
 (m
V)
3 6 9 12 18
0
5
10
15
20
age (months)
re
ac
tio
n 
tim
e 
(m
s)
*
3 6 9 12 18
0.0
0.5
1.0
1.5
2.0
2.5
3.0
age (months)
av
er
ag
e 
st
re
ng
th
3 6 9 12
0
50
100
150
200
250
300
350
age (months)
tim
e 
sp
en
t o
n 
th
e 
R
ot
ar
od
 (s
)
3 6 9 12
0.0
0.5
1.0
1.5
2.0
2.5
3.0
age (months)
av
er
ag
e 
st
re
ng
th
3 6 9 12
0
5
10
15
20
age (months)
re
ac
tio
n 
tim
e 
(m
s)
3 6 9 12
0
20
40
60
80
100
120
age (months)
C
M
A
Ps
 a
m
pl
itu
de
 (m
V)
139Acta Neuropathol (2018) 135:131–148 
1 3
compared to their WT littermates (Fig. 3c, d), similar as 
seen in the severe peripheral axon loss reported in the post-
mortem neuropathological analysis of a dHMN patient [58]. 
Quantification of the large neurons in the ventral horn of the 
spinal cord showed that despite the severe distal axon loss, 
the motoneuron cell bodies were spared (Supplementary Fig. 
S2a, b). Importantly, the reduction in axon density seen in 
18-month-old  Hspb8K141N/K141N mice could not be detected 
in 2-month-old mice (Supplementary Fig. S2c–e). This led 
us to attribute the axon loss in the  Hspb8K141N/K141N mice to 
progressive axonal degeneration rather than a developmental 
defect. In 12-month-old  Hspb8K141N/+ mice (Supplementary 
Fig. S3a–c) and  Hspb8−/− mice (Supplementary Fig. S2f–h), 
similar analyses failed to demonstrate axon loss, supporting 
the absence of neuropathy in these mice. At the ultrastruc-
tural level, distal sciatic nerves of 18-month-old  Hspb8K141N/
50 µm
ca b
k
*
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Fig. 3  Characterization of distal sciatic nerve pathology associated 
with  Hspb8K141N mutation. a, b Toluidine-blue stained semi-thin 
sections of the tibial nerve of 18-month-old WT  Hspb8+/+ (a) and 
 Hspb8K141N/K141N (b) mice. c Density of large and medium myeli-
nated axons in the tibial nerve of 18-month-old  Hspb8K141N/K141N 
and  Hspb8+/+ mice. Values are expressed as mean  ±  SD, N  =  3. 
**p<0.01. d Axon diameter distribution. Values are expressed as 
mean  ±  SD, N  =  3. e, f Electron microscopy images of the tibial 
nerve of 18-month-old  Hspb8K141N/K141N mice showing axonal degen-
eration (arrow), regenerative clusters (arrow head), and macrophages 
(asterisk). g, h Electron microscopy images of the sural nerve of the 
CMT-M:V.6 patient showing a regenerative cluster (g) and an onion-
bulb like pattern (h). i Electron microscopy images of the tibial 
nerve of  Hspb8K141N/K141N mice showing axoplasmic accumulation 
of osmiophilic material. j Higher magnification micrograph of the 
accumulated axoplasmic material showing mitochondria undergoing 
mitophagy (arrow heads). k Total number of axoplasmic clusters per 
nerve cross section in  Hspb8K141N/K141N mice and controls. Values are 
expressed as mean ± SD, N = 3. *p<0.05
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K141N mice demonstrated histopathological changes such as 
axonal atrophy, regenerative clusters, and infiltration by 
macrophages (Fig. 3e–f). In addition,  Hspb8K141N/K141N mice 
sciatic axons displayed focal accumulations of mitochondria, 
some of them undergoing mitophagy, as well as other degen-
erating organelles (Fig. 3i, j). This accumulation of axoplas-
mic material has already been described in a case of CMT2E 
neuropathy caused by NEFL gene mutations [26, 84] and is 
thought to result from axoplasmic flow disturbance. These 
clusters of axoplasmic degenerative material were signifi-
cantly more frequent in  Hspb8K141N/K141N than in WT mice 
(Fig. 3k). Interestingly, the distal sciatic nerve of heterozy-
gous  Hspb8K141N/+ mice also displayed, although to a lesser 
extent, regenerative clusters, macrophage infiltration, and 
accumulation of axoplasmic material (Supplementary Fig. 
S3d, e), as well as myelinated Remak bundles which suggest 
abnormal cycles of regeneration and remyelination (Sup-
plementary Fig. S3f). It is so far difficult to determine if the 
sciatic nerve of HSPB8-linked dHMN II patients shows a 
similar pattern because of the absence of motor nerve biop-
sies. However, a biopsy of the sensory branch of the super-
ficial peroneal nerve of one patient belonging to the large 
Belgian family with the HSPB8_K141N mutation (patient 
CMT-M:V.6) was analysed and no major abnormalities were 
found in the ultrastructure apart from a regenerative cluster 
(Fig. 3g), three small Schwann cell onion bulb-like forma-
tions (Fig. 3h), and a minimal reduction in unmyelinated 
axons [77].
Hspb8K141N/K141N mice develop muscle atrophy 
with myofibrillar alterations
The peroneal brevis muscle biopsy of the same CMT-
M:V.6 patient showed a total fatty degeneration with only 
few residual atrophic muscle fibers [77]. This led us to pro-
ceed with the histopathology of a hind limb distal muscle 
innervated by the sciatic nerve, the gastrocnemius muscle. 
Haematoxylin and eosin (HE) staining of transversal sec-
tions of the gastrocnemius muscle showed that the myofibers 
of 2-month-old  Hspb8K141N/K141N (Fig. 4d) and WT mice 
(Fig. 4a) were of regular size and displayed a normal mor-
phology with most nuclei positioned at the normal subsar-
colemmal location. In contrast, the 9-month-old  Hspb8K141N/
K141N mice (Fig. 4e), but not their WT littermates (Fig. 4b), 
displayed an increased number of myofibers with non-sub-
sarcolemmal nuclei, a marked discrepancy in myofiber size, 
some of them being atrophic, and several rimmed vacuoles. 
In the 12-month-old  Hspb8K141N/K141N mice gastrocnemius 
muscle, internalized nuclei were more frequent, size vari-
ability was markedly increased, and angulated (but non-
grouped), and rounded atrophic fibers could be seen as well 
as hypertrophic fibers, clumped nuclei, rimmed vacuoles, 
and endomysial fibrosis (Fig. 4f). Notably, the myofibers of 
12-month-old WT mice also showed some size variability 
(Fig. 4c), but much less pronounced than in  Hspb8K141N/
K141N mice, reflecting the normal aging process of skeletal 
muscle in these mice. Interestingly, the fiber-type pattern of 
the  Hspb8K141N/K141N mice was not grouped and was similar 
to WT littermates (Supplementary Fig. S4e–f), suggesting 
that the muscle atrophy had a myogenic rather than neu-
rogenic origin. The myopathic phenotype in  Hspb8K141N/
K141N mice was further validated and refined by EM analy-
ses showing severe myofiber degeneration (Fig. 4g), accu-
mulations of electron dense granulofilamentous material 
(Fig. 4h), and ring fibers (Fig. 4i); these features are often 
associated with myofibrillar myopathy (MFM) [17]. These 
data echo the recent description of a MFM-like phenotype in 
two families with the HSPB8 (c.421A > G;p.K141E) muta-
tion [34]. The H&E-stained muscle sections of 12-month-old 
heterozygous  Hspb8K141N/+ mice were comparable to WT 
(Supplementary Fig. S3 g, h), while EM analysis revealed 
signs of Z-band disintegration (Supplementary Fig. S3i), 
accumulation of electron-dense material (Supplementary 
Fig. S3j), and a small, empty vacuole (Supplementary Fig. 
S3 k). Similar histopathological studies were carried out in 
the KO lines and showed a subtle increase in myofiber size 
variability in  Hspb8−/− mice (Fig. 4j–l) with age comparable 
to what was seen in WT animals. Further EM analyses in 
the gastrocnemius of  Hspb8−/− mice showed the absence 
of atrophic or necrotic fibers, preserved Z-disc structure 
(Fig. 4m), and accumulation of pathologic mitochondria 
many of which presented with degenerating cristae and 
abnormal matrix (Fig. 4n, o). These data suggest that loss 
of function of Hspb8 may affect mitochondrial homeostasis, 
but does not lead to myofibrillar myopathy, while mutant 
Hspb8 causes progressive and severe myopathy with a dis-
tinct myofibrillar component.
Fig. 4  Gastrocnemius muscle histopathology in the  Hspb8K141N KI 
and Hspb8 KO lines. a, c Haematoxylin and eosin (H&E)-stained 
cross sections of the gastrocnemius muscle of 2-month-old (a), 
9-month-old (b) and 12-month-old (c)  Hspb8+/+ mice. d, f H&E-
stained cross sections of the gastrocnemius muscle of 2  month old 
(d), 9-month-old (e), and 12-month-old (f)  Hspb8K141N/K141N mice. 
e, f Rimmed vacuoles (black arrows), necrotic (white arrowheads), 
atrophied (black arrowheads), and hypertrophic fibers (asterisks) 
in 9-month-old (e) and 12-month-old (f)  Hspb8K141N/K141N mice. 
g, i Electron microscopy images of the gastrocnemius muscle of a 
12-month-old  Hspb8K141N/K141N mouse showing myofibers at different 
stages of atrophy (g); accumulation of granulofilamentous material 
(h) and a ring fiber showing classical features with peripheral longi-
tudinal myofibrils and centrally transverse myofibrils (i). j, l H&E-
stained cross sections of the gastrocnemius muscle of 2-month-old 
(j), 9-month-old (k) and 12-month-old (l)  Hspb8−/− mice. m–o Elec-
tron microscopy images of the gastrocnemius muscle of a 12-month-
old  Hspb8−/− mouse showing intact myofibrils and normal Z-disc 
organisation (m), enlarged mitochondria with altered cristae (arrow) 
(m), accumulation of altered mitochondria, some possibly undergoing 
mitophagy (n), and mitochondria presenting degenerating cristae and 
abnormal matrix (arrow heads) (o)
◂
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Mutant Hspb8 causes aggregation of myofibril 
components and autophagy defects in the muscle
Because aggregation of myofibrillar or ectopic proteins 
is a major hallmark of MFM [47], we looked for desmin 
and αB-crystallin, also known as HSPB5 or CRYAB, in 
the muscle of 12-month-old  Hspb8K141N/K141N mice and 
their WT littermates. While αB-crystallin immunoreac-
tivity was found sub-sarcolemmaly and colocalizing with 
the Z-disc in the WT animals (Fig. 5a), large aggregates 
were observed in many muscle fibers of the  Hspb8K141N/
K141N mice (Fig. 5b). Similar patterns were observed for 
desmin (Fig. 5d, e). No αB-crystallin and desmin aggre-
gates were found in the 12-month-old  Hspb8−/− mice 
(Fig. 5c, f) which corroborates with the absence of an 
MFM phenotype in these mice. As expected, Hspb8 
forms also aggregates in  Hspb8K141N/K141N mice (Fig. 5h), 
while it follows a certain sarcomeric structure in WT 
(Fig. 5g). Comparable aggregates could not be found 
in  Hspb8K141N/+ mice (Supplementary Fig. S3l). As 
expected, no Hspb8 immunoreactivity could be seen in 
KO tissue (Fig. 5i). Taken together, these findings are in 
concordance with the HSPB8, desmin, and αB-crystallin 
aggregates found in the patients with a different mutation 
in the same lysine residue, the K141E missense mutation 
[34]. To expand our understanding of the disease mecha-
nism, we proceeded with protein expression analyses of 
Hspb8 and its main interactor Bag3 in 2-month-old (pre-
symptomatic) and 12-month-old (symptomatic) mice. In 
addition, we also quantified the protein levels of p62, 
a substrate for autophagy, and of the autophagosome-
associated lipidated form of LC3B (LC3BII), both used 
as common markers for autophagy. Compared to WT lit-
termates, the muscle of symptomatic  Hspb8K141N/K141N 
mice displayed a significant increase in HSPB8, p62, and 
LC3BII, while Bag3 levels were decreased (Fig. 5j, k). 
For p62, an increase could also be observed in 2-month-
old  Hspb8K141N/K141N mice. The increase in Hspb8 level 
observed in 12-month-old  Hspb8K141N/K141N mice corre-
lates with the accumulation of Hspb8 aggregates previ-
ously described. The downregulation of the Bag3 protein 
level in the same mice could suggest a deficit in Bag3-
mediated autophagy. In addition, the significant increase 
in p62, a substrate of autophagy, in 2-month-old and 
12-month-old  Hspb8K141N/K141N mice (Fig. 5j, k) could 
reflect a failure in autophagy. The increase in LC3BII, 
a marker of autophagosomes, could either reflect an 
increase in autophagy flux, which is somewhat incompat-
ible with the higher p62 and lower Bag3 levels, or reflect 
an accumulation of autophagosomes that fail to fuse with 
lysosomes, a known consequence of the missense muta-
tion in HSPB8 [50].
Mutant Hspb8 forms aggregates and causes low 
autophagy power in the sciatic nerve
Similar to the muscle, we found Hspb8-positive aggre-
gates in symptomatic 18-month-old  Hspb8K141N/K141N mice 
(Fig. 6b) but not in  Hspb8K141N/+ mice (supplementary 
Fig. S3m) or WT littermates (Fig. 6a). We then measured 
the amount of proteins involved in Hspb8/Bag3-mediated 
autophagy in 2-month-old and 12-month-old mice by west-
ern blot. The levels of Hspb8 and Bag3 were significantly 
reduced in the sciatic nerve of 2-month-old  Hspb8K141N/K141N 
mice (Fig. 6c, d). The level of Bag3 was also drastically 
reduced in 12-month-old  Hspb8K141N/K141N mice, whereas 
Hspb8 protein level was comparable to WT. The levels of 
p62 were similar to WT both in pre-symptomatic and symp-
tomatic  Hspb8K141N/K141N mice. The lipidated form of LC3B 
could not be detected in sciatic nerve tissue. The absence of 
detectable LC3BII band was specific to the sciatic nerve, 
since we could detect it in other tissues from the same ani-
mals (Supplementary Fig. S5). We cannot explain this vari-
ability in LC3BII detection. One hypothesis could be that 
the level of autophagy or/and the speed of degradation of 
autophagosomes (where LC3BII is located) varies among 
tissues. The affected Hspb8 and Bag3 protein levels in the 
absence of p62 and LC3 alteration is reminiscent of the low 
“autophagy power” pattern described by Crippa et al. in the 
spinal cord of mutant SOD1 mice [18]. This reduced poten-
tial to activate the Hspb8/Bag3-mediated macroautophagy 
pathway could contribute to the pathogenesis by impairing 
the degradation of the mutant Hspb8 protein that accumu-
lates and progressively forms insoluble toxic aggregates.
Discussion
We generated a new transgenic mouse model for the 
 Hspb8K141N mutation causative of dHMN type II, CMT2L, 
and distal myopathy. The previous transgenic mouse models 
of mutant Hspb8 have been published [23, 66, 88], but this 
one is the first with a physiological and ubiquitous expres-
sion of the mutant protein. It is the first report of an Hspb8 
transgenic mouse line modelling distal myopathy and the 
faithful reproduction of a human hereditary neuromuscular 
disease phenotype by a mouse model is actually a rather 
rare event [6].
It is not entirely clear how independent the neuropathic 
and myopathic phenotypes are in our  Hspb8K141N/K141N mice. 
The histopathological analysis of the gastrocnemius mus-
cle showing normal fiber type pattern, granulofilamentous 
material accumulation, Z-disc disorganisation, and cytoskel-
etal component aggregates points toward a myopathy with 
myofibrillar component, distinct from a neurogenic muscle 
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Fig. 5  Aggregates of myofibrillar components and autophagy defects 
in the muscle of  Hspb8K141N/K141N mice. a–c αB-crystallin immuno-
histochemistry in 12-month-old  Hspb8+/+ (a),  Hspb8K141N/K141N (b) 
and  Hspb8−/− (c) mice, with notable dense subsarcolemmal and inter-
myofibrillar aggregates in  Hspb8K141N/K141N mice (b). d, f Desmin 
immunohistochemistry in 12-month-old  Hspb8+/+ (d),  Hspb8K141N/
K141N (e) and  Hspb8−/− (f) mice showing aggregates (asterisk) in 
some myofibers of  Hspb8K141N/K141N mice (e). g, h Hspb8 immu-
nohistochemistry in 12-month-old  Hspb8+/+ (g), in 12-month-old 
 Hspb8K141N/K141N, showing numerous myofibers containing aggre-
gates (h), and in 12-month-old  Hspb8−/− (i). j Western blot showing 
Hspb8, Bag3, p62, and LC3B in muscle lysates of 2-and 12-month-
old  Hspb8K141N/K141N and WT mice. GAPDH is used as a load-
ing control. k Quantification of the Hspb8, Bag3, p62, and LC3BII 
bands normalized on GAPDH. *p  <  0.05. Values are expressed as 
mean ± SD, N = 3
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atrophy. On the other hand, the muscle, the nerve, and the 
motor neurons are the components of the same neuromus-
cular axis. They are interdependent and are also particularly 
dependent on a well-functioning proteostatic system. Dener-
vation leads to major changes in proteostasis in the affected 
muscle fibers, including myofibrillar remodeling and target 
formation, and induces a dynamic response involving chap-
erons, endoplasmic reticulum, and autophagy-related pro-
teins [44]. Mutation in these proteins will affect the motor 
unit’s ability to respond to denervation and might trigger a 
disproportionate “bystander” myopathy. This is supported 
by the observation that mutations in the same proteins can 
cause both neuropathies, motor neuron diseases and vacuolar 
myopathies [5, 25, 34, 44, 45, 56, 72, 76].
The heterozygous  Hspb8K141N/+ mice, which have an 
allelic pattern closer to the patient situation, have a much 
milder phenotype and fail to develop motor deficits. The 
need of a higher expression of the mutant protein to observe 
a functional phenotype is not peculiar when modelling 
inherited disease [7, 88] and underlines the discrepancies 
between transgenic mice and human patients, between their 
respective lifespan, the disease duration, and the complexity 
of their environment.
Our model allowed the generation of a functional KO 
line in parallel with the  Hspb8K141N KI lines. An Hspb8 
KO mouse model has already been developed by others to 
determine the function of Hspb8 in cardiac tissues, where 
it is highly expressed [61]. Although that Hspb8 KO had a 
normal behaviour and physiology, they showed an increased 
susceptibility to heart failure under the specific context of 
cardiac overload [61]. Our Hspb8 KO  (Hspb8−/−) mice did 
not develop a neuropathic or myopathic phenotype. The 
absence of myofiber defect was unexpected, since HSPB8 
participates in myofibril stabilisation through the CASA 
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p62 bands normalized on GAPDH. *p < 0.05. Values are expressed 
as mean ± SD, N = 3
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complex [38, 79, 80]. Furthermore, depletion of Hspb1, 
another member of the sHSP family whose mutant form has 
also been associated with myopathy, leads to myofiber ultra-
structural defects [46]. Although the  Hspb8−/− myofibers 
did not undergo atrophy and degeneration, they presented 
an accumulation of abnormally patterned mitochondria. 
Interestingly, comparable structural abnormalities of mito-
chondria have already been associated with myopathy [57, 
83]. This particular susceptibility of mitochondria to Hspb8 
deficiency could be attributed to the involvement of Hspb8 
in mitochondrial membrane potential maintenance and oxi-
dative phosphorylation [42, 52, 62]. Still, the absence of a 
phenotype in our KO mice demonstrates that Hspb8 loss-
of-function is insufficient to produce a strong neuropathic 
or myopathic phenotype. This implies that a toxic gain-of-
function of mutant Hspb8 plays a key role in the pathogen-
esis of both diseases in our mouse model. However, a recent 
report describes several patients with an HSPB8 frameshift 
mutation leading to haploinsufficiency associated with a late 
(adult) onset myopathy but not with neuropathy [25]. This 
suggests that some loss-of-function mechanisms also play 
a role in the development of HSPB8-associated myopathy.
The toxicity of mutant Hspb8 could result from its ten-
dency to accumulate and form large aggregates in the sci-
atic nerve and myofibers of  Hspb8K141N/K141N mice. We 
have previously shown that mutant  Hspb8K141N is prone to 
aggregation in patient-derived material [42]. While a few 
additional studies have associated mutant protein aggrega-
tion to axonal neuropathy [67, 78, 87], there is thus far no 
clear consensus on how these aggregates contribute to the 
neurodegeneration. Myofibrillar myopathy (MFM) is also 
caused by aggregation-prone mutations in proteins associ-
ated with the Z-disc [4, 10, 53, 71], including αB-crystallin, 
SQSTM1, and BAG3, which interact with HSPB8 to mediate 
chaperone-assisted-selective autophagy (CASA), a process 
required for the maintenance of myofibrils.
The MFM phenotype associated with BAG3 mutation is 
thought to result from the progressive accumulation of insol-
uble BAG3 aggregates and the impairment of the CASA 
complex to remove these aggregates [49, 64]. In parallel, the 
neuropathic and myopathic phenotypes in the  Hspb8K141N/
K141N mice could result from the progressive aggregation of 
mutant Hspb8 and a reduced ability to remove these aggre-
gates. Indeed, the accumulation of aggregate-prone proteins 
can be prevented by Hspb8 and Bag3 [12, 16, 20, 21], whose 
levels are affected in the sciatic nerve of our KI mice. In 
the muscle, the increase in p62 in post-symptomatic mice 
suggests a defect in the autophagic flux. The higher levels 
of LC3BII detected in post-symptomatic  Hspb8K141N/K141N 
mice compared to WT could result from the accumula-
tion of autophagosomes unable to fuse with lysosomes and 
complete the autophagy flux, since mutant  Hspb8K141N was 
shown to impair the fusion of autophagosomes with lys-
osomes [50].
Altogether, our results lead us to conclude that the accu-
mulation of mutant  Hspb8K141N combined with an inabil-
ity to degrade Hspb8-positive aggregates through Hspb8/
Bag3-mediated autophagy is a key pathomechanism under-
lying the peripheral neuropathy and distal myopathy in 
our mouse model. Accumulation of toxic protein clusters 
within the neuronal soma could be tolerated; however, toxic 
protein accumulation within the confined long peripheral 
axons could on long-term disturb axoplasmic flow to the 
distal axon and synapse. Finally, our study demonstrates that 
the generation of KI and KO mouse lines is a relevant and 
powerful tool to understand the gain- and loss-of-function 
mechanisms taking part in the pathogenesis of neuromus-
cular diseases.
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